Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
137 items
A fundus photo of a patient with reticular pseudodrusen shows a giraffe-like macular pattern.

NIH launches international study of AMD progression

A new clinical study led by the National Eye Institute (NEI), part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early age-related macular degeneration (AMD).

NIH discovery brings stem cell therapy for eye disease closer to the clinic

Scientists at the National Eye Institute (NEI) report that tiny tube-like protrusions called primary cilia on cells of the retinal pigment epithelium (RPE) are essential for the survival of the retina’s light-sensing photoreceptors.
Grantee News

Macular Degeneration: UVA Discovers Trigger That Leads to Vision Loss for Millions

In a major step forward in the battle against macular degeneration, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the damaging inflammation that ultimately robs millions of their sight.
Xu Wang with Wai Wong in lab

Breast cancer drug dampens immune response, protecting light-sensing cells of the eye

The breast cancer drug tamoxifen appears to protect light-sensitive cells in the eye from degeneration, according to a new study in mice.
Grantee News

Fighting Blindness: TSRI Scientists Bring a Key Protein into Focus

NEI-funded scientists from The Scripps Research Institute have discovered how a protein called α2δ4 establishes proper vision.
Grantee News

New Method to Detect Ultrasound with Light

A tiny, transparent device that can fit into a contact lens has a bright future, potentially helping a range of scientific endeavors from biomedicine to geology.
Grantee News

USC Roski Eye Institute researchers publish largest eye study of age-related macular degeneration in Latino population that analyzes impact on quality of life

The University of Southern California (USC) Roski Eye Institute researchers and clinicians published results of the largest population-based study of adult Latinos and age-related macular degeneration (AMD).
Patient undergoes and eye exam. Courtesy National Eye Institute.

Age-related macular degeneration before and after the era of anti-VEGF drugs

In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better after five years of treatment with anti-VEGF drugs that are injected into the eye.
Grantee News

USC Roski Eye Institute Researchers Publish Largest Eye Study Among Chinese Americans Identifying More Effective Ways to Prevent and Treat Blinding Eye Diseases for This Racial Group

Researchers and clinicians at the University of Southern California Roski Eye Institute have published results of the NEI-funded “Chinese American Eye Study” in JAMA Ophthalmology.
Grantee News

Discovery Identifies New RX Target for Age-related Macular Degeneration & Alzheimer's

Researchers at LSU Health New Orleans have shown that a protein critical to the body’s ability to remove waste products from the brain and retina is diminished in age-related macular degeneration.